Table 3.
isotype | Minimal linear epitope | Ab sequences | Protection against VACVb | |||
---|---|---|---|---|---|---|
| ||||||
HC | LC | |||||
Mouse #1 | AD5 | 2b | ||||
AD10 | 3 | |||||
BF8 | 1 | − | ||||
FE11 | 2b | A | ||||
GH3 | 3 | |||||
JG8 | 3 | |||||
JE1 | 3 | a | ||||
LB8 | 3 | 76-88 | ||||
CE11 | 3 | |||||
DF8 | 3 | |||||
KD8 | 3 | B | ||||
LE11 | 3 | |||||
TH6 | 3 | |||||
BF9 | 2b | C | c | |||
HE6 | 2b | ++ | ||||
BB5 | 3 | D | d | |||
3G6 | 2b | |||||
4C5 | 3 | 76-90 | E | e | ||
Mouse #2 | 12G9 | 3 | ||||
12B4 | 3 | F | d | |||
9C3 | 2a | 71-90 | G | g | ++ | |
8C6 | 2a | ~12-64 | H | e | + |
++, similar to positive control (anti-H3 #41); −, similar to negative control (anti-A10, BG3); +, intermediate between positive and negative